Friday, December 5, 2008

Varying Congressional Views on New FDA Head

Article in the Wall Street Journal -- Lawmakers Divided Over Next FDA Head, Fixing Safety Issues, by Alicia Mundy.  Here's an excerpt:

A top House Democrat is asking President-elect Barack Obama to avoid naming any current officials of Food and Drug Administration to lead the agency, even temporarily, reflecting a divergence of views on Capitol Hill on how to fix the FDA's problems.

Congressional aides said Democratic officials have discussed naming Janet Woodcock, a longtime FDA official, as interim head after the expected departure of the current commissioner, Andrew von Eschenbach, a George W. Bush appointee. People close to the pharmaceutical industry also have been floating Dr. Woodcock's name as either interim or permanent FDA chief.

But Rep. Bart Stupak, a Michigan Democrat who holds a key post on the House committee that oversees the FDA, is seeking to forestall that choice. In a letter Wednesday to Mr. Obama, Rep. Stupak wrote, "I would encourage you not to appoint any current senior FDA employee as Commissioner or Interim Commissioner of the FDA."

BGS

http://lawprofessors.typepad.com/mass_tort_litigation/2008/12/varying-congres.html

FDA | Permalink

TrackBack URL for this entry:

http://www.typepad.com/services/trackback/6a00d8341bfae553ef0105363c0157970c

Listed below are links to weblogs that reference Varying Congressional Views on New FDA Head:

Comments

Post a comment